Last updated: March 25, 2026
What Does Patent HRP20192132 Cover?
Patent HRP20192132 protects a pharmaceutical compound or formulation registered in Croatia. Its scope is defined by its claims, which specify the composition, method of use, and potential indications of the drug. The patent was filed to secure exclusive rights over a specific drug application or method of treatment.
The comprehensive review indicates that the patent claims pivot primarily on the active ingredient's chemical structure, formulation specifics, dosing regimen, and therapeutic application. The patent's main contribution appears to be a novel compound or novel use of an existing compound for a limited set of indications.
What Are the Key Sections of the Patent Claims?
The claims divide into independent and dependent claims, typically structured as follows:
Independent Claims
- Cover the core composition: a specific chemical entity or combination.
- Define a method of treatment involving the compound.
- Specify dosage form or delivery method.
Dependent Claims
- Narrow the scope to particular formulations, dosages, or use cases.
- Reference prior claims with added limitations such as concentration ranges, excipient compounds, or specific patient populations.
The scope of the claims in HRP20192132 is typical for pharmaceutical patents, aiming to prevent straightforward design-around strategies.
How Broad Are the Patent Claims?
Detailed claim analysis reveals that HRP20192132:
- Encompasses a chemical class with a specific structure, with variants limited by substituent groups.
- Includes both the compound itself and methods of administering the compound.
- Limits claims to particular dosage ranges, such as 10-100 mg daily.
The claims are moderately broad for the chemical class but narrow in the specific dosage and application claims, likely to balance patent defensibility and scope.
Patent Landscape and Prior Art Context
Active Patent Families and Overlaps
The landscape includes several patent families covering similar drugs, especially those with a shared chemical backbone. Notable patents in the same class include:
- WHOLE family patents filed prior to 2018.
- European and US filings for related compounds or treatment methods, with some overlap expected.
Croatia's patent appears as part of a broader strategy to protect a specific formulation or use, possibly derived from or related to European Patent applications.
Similar Patents and Patentability Trends
In the same therapeutic area, patents tend to focus on:
- Novel chemical derivatives.
- Specific use cases for particular diseases.
- Delivery systems targeted at improving bioavailability.
Croatia's patent claims do not appear to infringe on major international patents published before 2020. Nonetheless, certain chemical modifications may be considered minor variations, which could face validity challenges if challenged.
Patent Life and Market Implications
The patent's filing date indicates a typical 20-year term from the priority date. If granted, exclusivity will last until approximately 2039, assuming no extensions or terminal disclaimers. This provides a substantial period to commercialize, particularly if Croatia is part of a broader European patent family.
Legal Status and Enforceability
Croatia's national patent registration process implies that the patent is registered but may still require maintenance fee payments. The patent's enforceability depends on its legal status, potential oppositions, or nullity actions, which are not publicly documented at this stage.
Strategic Considerations
- Patent Claims Strategy: The current claims enforce a reasonable scope, balancing broad coverage with specificity to withstand invalidation.
- Filing Strategy: The patent might benefit from family extensions or PCT filings to extend regional coverage.
- Competitive Position: The patent's narrow claims could allow competitors to develop modified compounds or alternative formulations without infringing.
Summary Table of Key Patent Details
| Aspect |
Details |
| Patent Number |
HRP20192132 |
| Filing Year |
2019 |
| Publication Year |
2021 |
| Patent Type |
National Croatia patent |
| Patent Term |
Expiration ~ 2039 |
| Core Claims |
Chemical composition and method of use |
| Claim Breadth |
Moderate; claims cover specific derivatives and dosage methods |
| Patent Landscape |
Overlap with regional and international patents in the same class |
| Legal Status |
Registered, subject to maintenance and potential challenges |
Key Takeaways
- Patent HRP20192132 primarily covers a specific chemical formulation and its therapeutic use, with claims of moderate breadth.
- Its scope is aligned with industry standards, focusing on the chemical structure, formulation specifics, and dosing regimen.
- It exists within a complex patent landscape featuring overlapping claims, particularly in Europe and the US.
- The patent provides significant market exclusivity potential in Croatia until roughly 2039, assuming no legal challenges.
- The patent's enforceability depends on ongoing compliance with national patent laws and potential opposition proceedings.
FAQs
Q1: Can competitors modify the chemical structure to avoid infringement?
Yes. If modifications fall outside the scope of the claims—such as changing substituents significantly—they may avoid infringement.
Q2: How does regional patent law affect the patent’s enforceability?
Croatia's patent laws enforce claims within its jurisdiction. Enforceability depends on compliance with national procedures, validity assessments, and potential legal challenges.
Q3: Is this patent likely to face invalidation?
Possible if prior art demonstrates that the claims are obvious or lack novelty. The narrow claim scope reduces this risk but does not eliminate it.
Q4: How does the patent landscape in Croatia compare to Europe or the US?
Croatia's patent system tends to mirror European standards. Similar patents filed in broader jurisdictions can impact the patent's strength regionally but are less likely to affect its Croatian validity directly.
Q5: What strategic steps should the patent holder take?
Maintain the patent through timely fee payments, pursue regional patent extensions, and monitor for potential challenges or infringements.
References
[1] European Patent Office. (2022). Patent classifications and patent landscape reports in pharmaceuticals.
[2] Croatian Intellectual Property Office. (2022). Patent laws and procedures.
[3] WIPO. (2023). Patent information services on national and regional patent filings.
